myirislogo
23 December, 2014 02:47 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 307.65 1.12
Infosys 1997.00 0.24
Tata Stl 403.85 0.33
Sslt 210.80 1.22
Icici Bank 358.85 0.97
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Lifeline Drugs & Pharma Limited
Lifeline Drugs & Pharma Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:506113NSE:NABloomberg:LDPL@INReuters:LIFE.BO
Market Lot: 1Face Value: 1ISIN Demat: INE776N01028
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
27-SEP-13 Lifeline Drugs & Pharma said on Thursday its board of directors will meet on October 01, 2013 to consider splitting, sub-division of face value of equity shares. 26-SEP-13 Lifeline Drugs & Pharma said that its board of directors will meet on Oct. 01, 2013, to consider split/sub-division of face value of shares. Future Plans The company is expected to set up a greenfield project for manufacturing bulk drugs and intermediates and ...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
  -
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 138.43400.780.00
Other Income4.367.682.86
Total Income142.79408.462.86
Cost of goods sold137.30398.690.82
OPBDIT5.499.772.04
PAT5.486.551.41
Gross Block---
Equity capital36.2436.2430.74
EPS (Rs.)-0.180.46
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-200.56 - 3246.3918.48 - 74.78
Debt / Equity (x)---
Operating margin (% of OI) 3.8 2.471.3
Net margin (% of OI) 3.8 1.649.3
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
Not Available
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer